Evaluation of Hearing Level in Patients on Long Term Aspirin Therapy

Overview

Journal F1000Res

Specialties Biomedical Engineering
Science

Date 2018 Aug 10

PMID 29707192

Citations 2

Authors

Apar Pokharel

Sangita Bhandary

Affiliations

Soon will be listed here.

Abstract

: Aspirin is a routinely prescribed drug, most notably for cardiovascular diseases, such as myocardial ischemia. This cross sectional, comparative study study aims to explore differences in hearing status between the cardiovascular disease patients on aspirin therapy and age matched controls. : The study population consisted of 182 patients with heart disease taking long term aspirin (i.e., for more than one year). The control population consisted of 221 age matched controls who were not taking aspirin. : It was found that age of patient, not aspirin intake, was more important risk factor contributing to hearing loss. : When confounding factors like age of the patient, hypertension and diabetes were taken into account, aspirin in its antiplatelet dose was not found to be the cause of any audiological problems like tinnitus and hearing loss.

Citing Articles

Audiological Profile in Patients of Chronic Stable Angina with Hearing Loss.

Dwivedi P, Kanaujia S, Srivastava A, Kaul P, Sharma A, Kanawjia P Indian J Otolaryngol Head Neck Surg. 2025; 77(2):741-748.

PMID: 40070746 PMC: 11890837. DOI: 10.1007/s12070-024-05235-0.

Which Environmental Pollutants Are Toxic to Our Ears?-Evidence of the Ototoxicity of Common Substances.

Zarus G, Ruiz P, Benedict R, Brenner S, Carlson K, Jeong L Toxics. 2024; 12(9).

PMID: 39330578 PMC: 11435700. DOI: 10.3390/toxics12090650.

Evaluation of hearing level in patients on long term aspirin therapy.

Pokharel A, Bhandary S F1000Res. 2018; 6:445.

PMID: 29707192 PMC: 5909044. DOI: 10.12688/f1000research.11131.2.

References

Jung T, Rhee C, Lee C, Park Y, Choi D . Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs, and quinine. Otolaryngol Clin North Am. 1993; 26(5):791-810. View

Shi X . Physiopathology of the cochlear microcirculation. Hear Res. 2011; 282(1-2):10-24. PMC: 3608480. DOI: 10.1016/j.heares.2011.08.006. View

Gratton M, Schulte B . Alterations in microvasculature are associated with atrophy of the stria vascularis in quiet-aged gerbils. Hear Res. 1995; 82(1):44-52. DOI: 10.1016/0378-5955(94)00161-i. View

Brancaleone V, Gobbetti T, Cenac N, Le Faouder P, Colom B, Flower R . A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood. 2013; 122(4):608-17. PMC: 3724196. DOI: 10.1182/blood-2013-04-496661. View

Curhan S, Eavey R, Shargorodsky J, Curhan G . Analgesic use and the risk of hearing loss in men. Am J Med. 2010; 123(3):231-7. PMC: 2831770. DOI: 10.1016/j.amjmed.2009.08.006. View

Ohlemiller K . Mechanisms and genes in human strial presbycusis from animal models. Brain Res. 2009; 1277:70-83. PMC: 2792931. DOI: 10.1016/j.brainres.2009.02.079. View

Young Chung H, Cesari M, Anton S, Marzetti E, Giovannini S, Seo A . Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 2008; 8(1):18-30. PMC: 3782993. DOI: 10.1016/j.arr.2008.07.002. View

Agrawal Y, Platz E, Niparko J . Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med. 2008; 168(14):1522-30. DOI: 10.1001/archinte.168.14.1522. View

Sakaguchi N, SPICER S, Thomopoulos G, Schulte B . Immunoglobulin deposition in thickened basement membranes of aging strial capillaries. Hear Res. 1997; 109(1-2):83-91. DOI: 10.1016/s0378-5955(97)00048-8. View

10.

BRIEN J . Ototoxicity associated with salicylates. A brief review. Drug Saf. 1993; 9(2):143-8. DOI: 10.2165/00002018-199309020-00006. View

11.

Nelson E, Hinojosa R . Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature. Laryngoscope. 2006; 116(9 Pt 3 Suppl 112):1-12. DOI: 10.1097/01.mlg.0000236089.44566.62. View

12.

Gates G, Mills J . Presbycusis. Lancet. 2005; 366(9491):1111-20. DOI: 10.1016/S0140-6736(05)67423-5. View

13.

Singh T, Newman A . Inflammatory markers in population studies of aging. Ageing Res Rev. 2010; 10(3):319-29. PMC: 3098911. DOI: 10.1016/j.arr.2010.11.002. View

14.

Wiley T, Chappell R, Carmichael L, Nondahl D, Cruickshanks K . Changes in hearing thresholds over 10 years in older adults. J Am Acad Audiol. 2008; 19(4):281-92. PMC: 2802451. DOI: 10.3766/jaaa.19.4.2. View

15.

Cruickshanks K, Wiley T, Tweed T, Klein B, Klein R, Nondahl D . Prevalence of hearing loss in older adults in Beaver Dam, Wisconsin. The Epidemiology of Hearing Loss Study. Am J Epidemiol. 1998; 148(9):879-86. DOI: 10.1093/oxfordjournals.aje.a009713. View

16.

Omran A . The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q. 2005; 83(4):731-57. PMC: 2690264. DOI: 10.1111/j.1468-0009.2005.00398.x. View

17.

Stypulkowski P . Mechanisms of salicylate ototoxicity. Hear Res. 1990; 46(1-2):113-45. DOI: 10.1016/0378-5955(90)90144-e. View

18.

Nash S, Cruickshanks K, Klein R, Klein B, Nieto F, Chappell R . Long-term variability of inflammatory markers and associated factors in a population-based cohort. J Am Geriatr Soc. 2013; 61(8):1269-76. PMC: 3743937. DOI: 10.1111/jgs.12382. View

19.

Lee F, Matthews L, Dubno J, Mills J . Longitudinal study of pure-tone thresholds in older persons. Ear Hear. 2005; 26(1):1-11. DOI: 10.1097/00003446-200502000-00001. View

20.

Bainbridge K, Hoffman H, Cowie C . Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Survey, 1999 to 2004. Ann Intern Med. 2008; 149(1):1-10. PMC: 2803029. DOI: 10.7326/0003-4819-149-1-200807010-00231. View